Organisation paid for research Program year 2025 Source: CMS Open Payments

American Research Corp

Neither a doctor nor a teaching hospital

Research payments

$2,536,275

659 payments

Through program year 2025, American Research Corp is reported as receiving $2,536,275 in research payments, across 659 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$94,880	4
2024	Research	$1,158,585	7
2023	Research	$269,452	7
2022	Research	$575,023	83
2021	Research	$116,636	430
2020	Research	$215,813	92
2019	Research	$105,886	36

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $2,121,519 42 payments
Novo Nordisk AS $382,236 612 payments
La Jolla Pharmaceutical Company $32,519 5 payments

Studies the money was for Research payments · program years 2019–2025

A Phase 2A, Single Dose, Open-Label, Dose-Exploration Study to Assess $1,122,459 8 payments
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinet $715,025 25 payments
Nn9931-4492 $318,925 134 payments
A Phase 1, Open-Label Study to Investigate the Pharmacokinetics and SA $271,806 6 payments
Nn9931-4553 $49,672 262 payments
A Phase 2, Multi-Center, Randomized, Placebo Controlled, Double-Blind Study With Ljpc-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis $32,519 5 payments
Nn9500-4656 $13,639 216 payments
A Repeat Dose, Open Label, Two Period, Randomized, Cross Over Study to $12,230 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.